Reporter Sept 16 2022
Patient’s care journey included LVAD, bariatric surgery, transplant
Sep. 15, 2022—When Veronica Llamas-Barajas received a heart transplant at Vanderbilt University Medical Center in April, it was the culmination of a seven-year journey.
Study suggests new mechanism for lipid transporter
Sep. 15, 2022—A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.
Gifts bolster otolaryngology, Alzheimer’s disease programs
Sep. 15, 2022—Herbert Christopher, a grateful Otolaryngology–Head and Neck Surgery patient who received cochlear hearing implants from David Haynes, MD, has funded the training of otolaryngology fellows and leaders in Alzheimer’s disease care through several outright endowed gifts and additional gift planning with his estate.
Address highlights Pediatrics department’s growth
Sep. 14, 2022—Amid a year full of ongoing pandemic challenges, the Vanderbilt Department of Pediatrics’ “people” have driven the continued successes, achievements and growth of the department while also caring for more children than ever before, Steven Webber, MBChB, MRCP, said in his recent annual State of the Department address.
Hodges, Nakagawa receive Cohen Innovation funds
Sep. 14, 2022—Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds
Complementary research, resources, policies improve outcomes for those with substance use disorders: Panel
Sep. 14, 2022—A panel of experts on opioid use disorder (OUD) recently discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic.
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Sep. 13, 2022—Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.
VUMC leads effort to map heart disease-causing genetic variations
Sep. 13, 2022—Researchers from Vanderbilt University Medical Center, Stanford Medicine, the University of Toronto and Brigham and Women’s Hospital in Boston have joined forces to “map” the specific variations in more than 25 key cardiac disease genes that negatively affect heart function.
Monroe Carell Jr. Children’s Hospital at Vanderbilt and Cookeville Regional Medical Center announce agreement for pediatric and newborn services
Sep. 12, 2022—Leaders of Monroe Carell Jr. Children’s Hospital at Vanderbilt and the Vanderbilt Department of Pediatrics today announced an agreement with Cookeville Regional Medical Center to provide pediatric physician services.
